Filing Details

Accession Number:
0001209191-15-017271
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-23 16:59:17
Reporting Period:
2015-02-23
Filing Date:
2015-02-23
Accepted Time:
2015-02-23 16:59:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1269021 Portola Pharmaceuticals Inc PTLA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192591 J Charles Homcy C/O Portola Pharmaceuticals, Inc.
270 East Grand Ave.
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-23 20,000 $3.30 20,000 No 4 M Direct
Common Stock Disposition 2015-02-23 20,000 $40.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-02-23 20,000 $0.00 20,000 $3.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
190,067 2006-09-06 2016-06-06 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2014.
  2. These shares were sold in a single transaction at a price of $40.00.